Ribonuclease kappa (RNK), encoded by the RNASEK gene, is a cytoplasmic endoribonuclease that plays a critical role in degrading circular RNAs (circRNAs). Recent research has revealed that RNK deficiency leads to circular RNA accumulation in stress granules, disrupting RNA and protein homeostasis—a mechanism implicated in neurodegenerative diseases and aging.
RNK belongs to the RNase T2 family and is conserved across species from C. elegans to humans.
¶ Gene and Protein Structure
| Feature |
Value |
| Gene Symbol |
RNASEK |
| Chromosome |
17p11.2 |
| Protein Name |
Ribonuclease kappa |
| UniProt |
Pending characterization |
| Protein Family |
RNase T2 family |
- Molecular weight: ~25-30 kDa
- Cellular location: Cytoplasm, enriched in stress granules
- Expression: Ubiquitous, highest in brain tissue
- Substrate specificity: Circular RNAs (circRNAs), single-stranded RNA
RNK is an endoribonuclease with specificity for circular RNAs:
- Substrate: Circular RNAs (circRNAs)
- Cleavage pattern: Endonucleolytic cleavage within circRNA loops
- Cellular location: Cytoplasm, concentrated in stress granules
- Expression: Ubiquitous, higher in brain
RNK performs essential homeostatic functions:
- RNA quality control: Degrades aberrant or excess circRNAs
- Stress response regulation: Controls stress granule composition and dynamics
- Translation control: Prevents toxic circRNA accumulation that impairs protein synthesis
- Aging modulation: RNK levels decline with age, linking RNA metabolism to aging
Circular RNAs (circRNAs) are covalently closed RNA molecules formed by back-splicing:
- Formation: Back-splicing of pre-mRNA introns
- Stability: Highly stable due to circular structure (resistant to exonucleases)
- Normal functions: miRNA sponges, translation templates, gene regulation
- Pathology: Accumulation in aging and disease states
| Condition |
circRNA Level |
RNK Activity |
Cellular Consequence |
| Normal |
Low |
High |
Proper stress granule dynamics |
| Deficiency |
High |
Low |
circRNA accumulation in stress granules |
| Aging |
Elevated |
Declined |
Progressive RNA homeostasis disruption |
In RNK deficiency, circRNAs accumulate in stress granules:
- Sequestration: circRNAs become trapped in granules
- Disruption: Altered stress granule assembly/disassembly
- Toxicity: Impaired protein homeostasis
- Aggregation potential: circRNA-protein assemblies may seed pathological inclusions
Stress granules are membraneless organelles formed during cellular stress:
- Composition: mRNA, proteins, RNA-binding proteins
- Function: mRNA triage, translation arrest, stress response
- Dynamics: Assembly/disassembly is tightly regulated
- Dysfunction: Implicated in ALS, AD, PD
When RNK is deficient:
- circRNAs fail to be degraded
- circRNAs accumulate within stress granules
- Granule disassembly is impaired
- RNA-protein homeostasis is disrupted
- Cellular stress increases
- RNA homeostasis: Disrupted in AD brain
- Stress response: Chronic stress pathway activation
- Tau pathology: circRNA accumulation may interact with tau aggregates
- Therapeutic target: RNK enhancement strategies under investigation
- Stress granules: α-synuclein interaction with RNA granules
- RNA metabolism: Altered in PD models
- Research direction: RNK as therapeutic target
- RNA granules: TDP-43 pathology overlaps with stress granule dysfunction
- circRNA accumulation: Observed in ALS models
- Mechanistic link: Common pathway of RNA granule dysregulation
- Age-related decline: RNASEK expression decreases with age across species
- Lifespan effects: RNASEK knockdown reduces lifespan by ~20%; overexpression extends lifespan by ~30% in C. elegans
- Mouse models: Induced knockout causes frailty, weight loss, hunched posture
| Approach |
Status |
Notes |
| Gene therapy (AAV-RNK) |
Preclinical |
AAV delivery to brain |
| Small molecule activators |
Discovery |
Screen for RNASEK activators |
| circRNA-targeted approaches |
Early |
Reduce circRNA production |
Alternative therapeutic approaches:
- Stress granule disassembly: Therapeutic induction of granule clearance
- RNA binding protein modulators: Alter granule composition
- Combination therapy: Target both circRNA accumulation and protein aggregation
- circRNA levels in blood may indicate RNASEK activity
- Could serve as biomarkers for neurodegenerative diseases and biological age